Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line therapy for extensive-stage small-cell lung cancer

• Qiao Liu,

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Validation, Writing – review & editing

  Affiliation Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of China

  ⨯
• Chongqing Tan,

  Roles Validation

  Affiliation Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of China

  ⨯
• Lidan Yi,

  Roles Data curation

  Affiliation Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of China

  ⨯
• Xiaomin Wan,

  Roles Software, Validation

  Affiliation Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of China

  ⨯
• Liubao Peng,

  Roles Conceptualization, Supervision

  Affiliation Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of China

  ⨯
• Jianhe Li,

  Roles Supervision

  Affiliation Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of China

  ⨯
• Xia Luo ,

  Roles Data curation, Investigation

  * E-mail: zengxiaohui2008@csu.edu.cn (XZ); luoxia@csu.edu.cn (XL)

  Affiliation Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of China

  ⨯
• Xiaohui Zeng

  Roles Methodology, Writing – review & editing

  * E-mail: zengxiaohui2008@csu.edu.cn (XZ); luoxia@csu.edu.cn (XL)

  Affiliation Department of Nuclear Medicine/PET Image Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of China

  https://orcid.org/0000-0001-6050-4137

  ⨯